Molecular Targets for Cardioprotection: Where to Go?

Dear Colleagues,

Ischemic heart disease (IHD) is a leading cause of death and disability worldwide. Despite the intensive experimental research that has been conducted over the last three to four decades, there is currently no effective therapy for protecting the heart against failure following acute myocardial infarction, which is also termed cardioprotection. Therefore, the scientific community must dicover novel molecular targets for use in cardioprotection in order to improve the clinical outcomes of IHD patients. This is the overall objective of our EU-CARDIOPROTECTION COST Action (CA16225 http://www.cardioprotection.eu/); this comprises a European network of 100 leading cardioprotection researchers, all dedicated to realizing the therapeutic potential of novel cardioprotective therapies for the benefit of patients. This will be achieved through the discovery of novel therapeutic targets and strategies for cardioprotection (such as combination multitargeted therapies) as well as investigations into the confounding effects of co-morbidities and co-medication on cardioprotection.

Therefore, in this Special Issue of IJMS, entitled “Molecular Targets for Cardioprotection: Where to Go?", we invite you to submit both review and original preclinical articles on the topic of cardioprotection, with a special emphasis being placed on novel molecular targets. 

Prof. Dr. Ioanna Andreadou
Prof. Dr. Rainer Schulz
Prof. Dr. Péter Ferdinandy
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• Ischemic heart disease
• cardioprotective therapies
• cardioprotection